During the past decade, Enhancing Care Foundation conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Enhancing Care Foundation" are "Arthritis Juvenile Idiopathic" (1 trials) and "Juvenile Idiopathic Arthritis" (1 trials). Many other conditions were trialed in "Enhancing Care Foundation" in a lesser frequency.

Most popular intervention types in "Enhancing Care Foundation" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "In double-blind phase: treatment with tofacitinib or placebo in 1:1 ratio" (1 trials), "In open-label phase: treatment with tofacitinib" (1 trials) and "Tofacitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Enhancing Care Foundation" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Enhancing Care Foundation". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Enhancing Care Foundation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Enhancing Care Foundation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".